Genprex

-$0.05 (-3.45%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.

About GNPX

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer.

CEO
J. Rodney Varner
Employees
17
Headquarters
Austin, Texas
Founded
2009

GNPX Key Statistics

Market cap
67.06M
Price-Earnings ratio
—
Dividend yield
—
Average volume
93.40K
High today
$1.53
Low today
$1.39
Open price
$1.47
Volume
89.31K
52 Week high
$3.62
52 Week low
$1.17

GNPX Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure